Nu Skin Enterprises (NYSE:NUS – Get Rating) was upgraded by equities research analysts at TheStreet from a “c+” rating to a “b” rating in a report issued on Tuesday, TheStreetRatingsTable reports.
NUS has been the topic of a number of other research reports. DA Davidson raised their price objective on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a “neutral” rating in a research note on Thursday, February 17th. Jefferies Financial Group raised their price objective on shares of Nu Skin Enterprises from $61.00 to $75.00 in a research note on Thursday, February 17th. StockNews.com cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Friday, May 13th. Finally, Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 price objective on the stock in a research note on Tuesday, March 29th. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $60.60.
Shares of NYSE:NUS opened at $46.52 on Tuesday. Nu Skin Enterprises has a twelve month low of $39.40 and a twelve month high of $62.70. The company’s 50 day moving average is $46.44 and its 200 day moving average is $48.09. The company has a current ratio of 1.72, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. The company has a market cap of $2.34 billion, a PE ratio of 17.23 and a beta of 1.23.
In other Nu Skin Enterprises news, Chairman Steven Lund sold 21,200 shares of the firm’s stock in a transaction on Monday, May 16th. The stock was sold at an average price of $45.25, for a total value of $959,300.00. Following the transaction, the chairman now owns 180,374 shares in the company, valued at approximately $8,161,923.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Ryan S. Napierski sold 25,000 shares of the firm’s stock in a transaction on Wednesday, May 25th. The shares were sold at an average price of $44.91, for a total value of $1,122,750.00. Following the completion of the transaction, the chief executive officer now owns 122,683 shares in the company, valued at approximately $5,509,693.53. The disclosure for this sale can be found here. Insiders have sold a total of 71,993 shares of company stock worth $3,285,827 in the last quarter. Insiders own 2.80% of the company’s stock.
Hedge funds have recently made changes to their positions in the business. Morgan Stanley raised its holdings in shares of Nu Skin Enterprises by 1.9% during the 2nd quarter. Morgan Stanley now owns 360,382 shares of the company’s stock worth $20,415,000 after acquiring an additional 6,652 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Nu Skin Enterprises by 4.0% during the 3rd quarter. Goldman Sachs Group Inc. now owns 285,193 shares of the company’s stock worth $11,542,000 after acquiring an additional 10,977 shares during the period. Geode Capital Management LLC raised its holdings in shares of Nu Skin Enterprises by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 894,968 shares of the company’s stock worth $36,219,000 after acquiring an additional 17,566 shares during the period. Credit Suisse AG raised its holdings in shares of Nu Skin Enterprises by 13.3% during the 3rd quarter. Credit Suisse AG now owns 54,307 shares of the company’s stock worth $2,197,000 after acquiring an additional 6,391 shares during the period. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of Nu Skin Enterprises by 0.4% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 82,200 shares of the company’s stock worth $3,327,000 after acquiring an additional 340 shares during the period. Institutional investors own 93.79% of the company’s stock.
Nu Skin Enterprises Company Profile (Get Rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Recommended Stories
- Get a free copy of the StockNews.com research report on Nu Skin Enterprises (NUS)
- Chargepoint’s Stock Could Benefit from High Energy Prices
- Is It Too Late For Energy Stocks?
- MarketBeat Podcast: Get Your Mindset Right To Invest In The Current Market
- It’s Time To Get Interested In Ethereum Again
- Stratasys Stock Forming a Tradeable Bottom
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.